Predicting pain after standard pain therapy for knee osteoarthritis - the first steps towards personalized mechanistic-based pain medicine in osteoarthritis

被引:15
作者
Petersen, Kristian Kjaer-Staal [1 ,2 ]
机构
[1] Aalborg Univ, Fac Med, Ctr Neuroplast & Pain, Dept Hlth Sci & Technol, Fredrik Bajers Vej 7 D3, DK-9220 Aalborg, Denmark
[2] Aalborg Univ, Ctr Math Modelling Knee Osteoarthrit, Dept Mat & Prod, Aalborg, Denmark
基金
新加坡国家研究基金会;
关键词
mechanistic pain profiling; NSAIDs; osteoarthritis; quantitative sensory testing; total knee arthroplasty; CHRONIC POSTOPERATIVE PAIN; LONG NONCODING RNA; TEMPORAL SUMMATION; PHARMACOLOGICAL THERAPIES; REPLACEMENT SURGERY; CONTROLLED-TRIAL; REFERRED PAIN; MUSCLE PAIN; HIP; MODULATION;
D O I
10.1515/sjpain-2022-0082
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: The prevalence of osteoarthritis (OA) is rising, and pain is the hallmark symptom of OA. Pain in OA is complicated and can be influenced by multiple joint-related factors and factors related to, e.g., physiological, epigenetic, and pain sensory profiles. Increasing evidence suggests that a subset of patients with OA are pain sensitive. This can be assessed using quantitative sensory testing (QST). Common treatments of OA are total knee arthroplasty (TKA) and administration of 3-weeks of non-steroidal anti-inflammatory drugs (NSAIDs), which provide pain relief to many patients with OA. However, approx. 20% of patients experience chronic postoperative pain after TKA, whereas NSAIDs provide an average pain relief of approx. 25%. The current topical review focuses on the emerging evidence linking pretreatment QST to the treatment response of TKA and NSAID treatments. Content: MEDLINE was systematically searched for all studies from 2000 to 2022 on pretreatment QST, TKA, and NSAIDs. Pre-clinical studies, reviews, and meta-analyses were excluded. Currently, 14 studies on TKA and four studies on NSAIDs have been published with the aim to attempt prediction of the treatment response. The QST methodologies in the studies are inconsistent, but 11/14 (79%) studies on TKA and 4/4 (100%) studies on NSAIDs report statistically significant associations between pretreatment QST and chronic postoperative pain after TKA or analgesic effect after NSAID treatment. The strength of the associations remains low-to-moderate. The most consistent pretreatment QST predictors are pressure pain thresholds, temporal summation of pain, and conditioned pain modulation. Outlook: The use of QST as predictors of standard OA treatment is interesting, but the predictive strength remains low-to-moderate. A transition of QST from a research-based setting and into the clinic is not advised until the predictive strength has been improved and the methodology has been standardized.
引用
收藏
页码:40 / 48
页数:9
相关论文
共 96 条
[1]   Substantial rise in the lifetime risk of primary total knee replacement surgery for osteoarthritis from 2003 to 2013: an international, population-level analysis [J].
Ackerman, I. N. ;
Bohensky, M. A. ;
de Steiger, R. ;
Brand, C. A. ;
Eskelinen, A. ;
Fenstad, A. M. ;
Furnes, O. ;
Garellick, G. ;
Graves, S. E. ;
Haapakoski, J. ;
Havelin, L. I. ;
Makela, K. ;
Mehnert, F. ;
Pedersen, A. B. ;
Robertsson, O. .
OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (04) :455-461
[2]   Blockade of central cyclooxygenase (COX) pathways enhances the cannabinold-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception [J].
Ahn, Dong K. ;
Choi, Hyo S. ;
Yeo, Sang P. ;
Woo, Young W. ;
Lee, Min K. ;
Yang, Gwi Y. ;
Park, Jae S. ;
Mokha, Sukhbir S. .
PAIN, 2007, 132 (1-2) :23-32
[3]   Pain and sensitization after total knee replacement or nonsurgical treatment in patients with knee osteoarthritis: Identifying potential predictors of outcome at 12months [J].
Arendt-Nielsen, L. ;
Simonsen, O. ;
Laursen, M. B. ;
Roos, E. M. ;
Rathleff, M. S. ;
Rasmussen, S. ;
Skou, S. T. .
EUROPEAN JOURNAL OF PAIN, 2018, 22 (06) :1088-1102
[4]   A mechanism-based pain sensitivity index to characterize knee osteoarthritis patients with different disease stages and pain levels [J].
Arendt-Nielsen, L. ;
Egsgaard, L. L. ;
Petersen, K. K. ;
Eskehave, T. N. ;
Graven- Nielsen, T. ;
Hoeck, H. C. ;
Simonsen, O. .
EUROPEAN JOURNAL OF PAIN, 2015, 19 (10) :1406-1417
[5]   Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis [J].
Arendt-Nielsen, Lars ;
Egsgaard, Line Lindhardt ;
Petersen, Kristian Kjaer .
PAIN, 2016, 157 (08) :1634-1644
[6]   Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain [J].
Arendt-Nielsen, Lars ;
Skou, Soren T. ;
Nielsen, Thomas A. ;
Petersen, Kristian K. .
CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (04) :225-234
[7]   Translational musculoskeletal pain research [J].
Arendt-Nielsen, Lars ;
Graven-Nielsen, Thomas .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (02) :209-226
[8]   Sensitization in patients with painful knee osteoarthritis [J].
Arendt-Nielsen, Lars ;
Nie, Hongling ;
Laursen, Mogens B. ;
Laursen, Birgitte S. ;
Madeleine, Pascal ;
Simonsen, Ole H. ;
Graven-Nielsen, Thomas .
PAIN, 2010, 149 (03) :573-581
[9]  
Aveline C, 2014, CLIN J PAIN, V30, P749, DOI 10.1097/AJP.0000000000000033
[10]   Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations [J].
Bannister, Kirsty ;
Patel, Ryan ;
Goncalves, Leonor ;
Townson, Louisa ;
Dickenson, Anthony H. .
PAIN, 2015, 156 (09) :1803-1811